Faculty, Staff and Student Publications

Publication Date

11-13-2023

Journal

Cancer Cell

DOI

10.1016/j.ccell.2023.08.015

PMID

37738975

Abstract

Li et al. present a resource of single-cell RNA sequencing (scRNA-seq) data from the infusion products of relapsed or refractory large B cell lymphoma (rrLBCL) patients treated with standard-of-care axicabtagene ciloleucel and identify features that are significantly different between products from responders and non-responders at 3-month followup by PET/CT, an important landmark for long-term outcomes.

Keywords

Humans, Receptors, Chimeric Antigen, Positron Emission Tomography Computed Tomography, Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse, Antigens, CD19, T-Lymphocytes

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.